Efficacy of derazantinib (DZB) in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) expressing FGFR2-fusion or FGFR2 mutations/amplifications

Busset, MDD; Braun, S; El-Rayes, B; Harris, WP; Damjanov, N; Masi, G; Rimassa, L; Bhoori, S; Niger, M; Personeni, N; Braiteh, F; Lonardi, S; Engelhardt, M; Saulay, M; Schwartz, B; Shaib, WL; Mazzaferro, V; Papadopoulos, KP

ANNALS OF ONCOLOGY, 2019; 30 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索